Literature DB >> 6148939

Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome.

R J Wanders, M Kos, B Roest, A J Meijer, G Schrakamp, H S Heymans, W H Tegelaers, H van den Bosch, R B Schutgens, J M Tager.   

Abstract

The activity of peroxisomal enzymes was studied in human liver and cultured human skin fibroblasts in relation to the finding (Goldfischer, S. et al. (1973) Science 182, 62-64) that morphologically distinct peroxisomes are not detectable in patients with the cerebro-hepato-renal (Zellweger) syndrome. In homogenates of liver from the patients, dihydroxyacetone phosphate acyltransferase, a membrane-bound peroxisomal enzyme, is deficient (Schutgens, R.B.H., et al. (1984) Biochem. Biophys. Res. Commun. 120, 179-184). In contrast, there is no deficiency of the soluble peroxisomal matrix enzymes catalase, L-alpha-hydroxyacid oxidase and E-aminoacid oxidase. Catalase is also not deficient in homogenates of cultured skin fibroblasts from the patients. The results of digitonin titration experiments showed that in control fibroblasts at least 70% of the catalase activity is present in subcellular particles distinct from mitochondria or lysosomes. In contrast, all of the catalase activity in fibroblasts from Zellweger patients is found in the same compartment as the cytosolic marker enzyme lactate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148939     DOI: 10.1016/s0006-291x(84)80240-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  58 in total

1.  Peroxisome senescence in human fibroblasts.

Authors:  Julie E Legakis; Jay I Koepke; Chris Jedeszko; Ferdous Barlaskar; Laura J Terlecky; Holly J Edwards; Paul A Walton; Stanley R Terlecky
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

2.  In situ assay of fatty acid β-oxidation by metabolite profiling following permeabilization of cell membranes.

Authors:  Regina Ensenauer; Ralph Fingerhut; Sonja C Schriever; Barbara Fink; Marc Becker; Nina C Sellerer; Philipp Pagel; Andreas Kirschner; Torsten Dame; Bernhard Olgemöller; Wulf Röschinger; Adelbert A Roscher
Journal:  J Lipid Res       Date:  2012-02-16       Impact factor: 5.922

Review 3.  Targeting of proteins into the peroxisomal matrix.

Authors:  S Subramani
Journal:  J Membr Biol       Date:  1992-01       Impact factor: 1.843

4.  Topography of very-long-chain-fatty-acid-activating activity in peroxisomes from rat liver.

Authors:  W Lageweg; J M Tager; R J Wanders
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Low-density particles (W-particles) containing catalase in Zellweger syndrome and normal fibroblasts.

Authors:  J Aikawa; W W Chen; R I Kelley; K Tada; H W Moser; G L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Biosynthesis and maturation of peroxisomal beta-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease.

Authors:  A W Schram; A Strijland; T Hashimoto; R J Wanders; R B Schutgens; H van den Bosch; J M Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  A new type of chondrodysplasia punctata associated with peroxisomal dysfunction.

Authors:  B T Poll-The; P Maroteaux; C Narcy; P Quetin; M Guesnu; R J Wanders; R B Schutgens; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

8.  Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators.

Authors:  F Vaillant; J A Larm; G L McMullen; E J Wolvetang; A Lawen
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

9.  Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts.

Authors:  J A Gordon; L J Warnock; A A Spector
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).

Authors:  P B Lazarow; Y Fujiki; G M Small; P Watkins; H Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.